Overview
COVID-19 has impacted every industry and organization, and tobacco and nicotine product-focused manufacturers, retailers, public health organizations, and government agencies are no exception. Join this webinar to hear from leading experts on the extent and depth of how the COVID-19 pandemic has impacted tobacco and nicotine product regulators, manufacturers, and retailers, as well as predictions on the resulting long-term consequences on industry and enforcement. Registrants will also hear the latest on research into whether smoking, vaping, and nicotine use impacts the likelihood of contracting COVID-19 and/or worsens the symptoms of those who have contracted it.
Get Access
- +$100 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Speakers
Tony Abboud, Executive Director, Vapor Technology Association
Stefanie Miller, Managing Director, FiscalNote Markets
Jonathan Samet, Dean, Colorado School of Public Health
Moderated by  Kenneth Michael Cummings, Professor, Medical University of South Carolina
Virtual Learning FAQ
Related Content

 TONY ABBOUD is the Executive Director of the Vapor Technology Association (VTA) who has extensive experience in public policy, law, government, and politics. He has been instrumental in founding, growing, and leading VTA—the vapor industry’s national trade association, now with over 800 members covering every segment of the industry, including industry-leading device manufacturers, e-liquid manufacturers, distributors, flavor suppliers, and brick and mortar retailers. Mr. Abboud is recognized as a leading voice for essential regulations and a balanced discussion of the vapor industry, is a frequent speaker at national symposiums, and has been extensively quoted in the media, including national television and radio. Mr. Abboud earned his bachelor’s degree from Carleton College in 1988 and his JD with distinction from the University of Iowa College of Law in 1994.
TONY ABBOUD is the Executive Director of the Vapor Technology Association (VTA) who has extensive experience in public policy, law, government, and politics. He has been instrumental in founding, growing, and leading VTA—the vapor industry’s national trade association, now with over 800 members covering every segment of the industry, including industry-leading device manufacturers, e-liquid manufacturers, distributors, flavor suppliers, and brick and mortar retailers. Mr. Abboud is recognized as a leading voice for essential regulations and a balanced discussion of the vapor industry, is a frequent speaker at national symposiums, and has been extensively quoted in the media, including national television and radio. Mr. Abboud earned his bachelor’s degree from Carleton College in 1988 and his JD with distinction from the University of Iowa College of Law in 1994. STEFANIE MILLER is an industry-leading Tobacco investment research analyst based in Washington, DC. She specializes in the regulatory, legal, and political risks to the tobacco sector and companies therein. Her work over recent years has focused largely on the threats and opportunities to companies created by FDA’s tobacco regulations, Congressional tobacco control efforts, new entrants and innovative products entering the nicotine market, and public health distrust of the tobacco industry. Stefanie is a Managing Director at FiscalNote Markets where she also leads research in U.S. Politics and Elections, Trade Policy, and Cannabis. She appears frequently as a commentator on CNBC and Bloomberg TV, and is quoted frequently in financial press. Stefanie holds a Master of Business Administration from Georgetown University and a Bachelor Economics and Political Science from the University of Nebraska.
STEFANIE MILLER is an industry-leading Tobacco investment research analyst based in Washington, DC. She specializes in the regulatory, legal, and political risks to the tobacco sector and companies therein. Her work over recent years has focused largely on the threats and opportunities to companies created by FDA’s tobacco regulations, Congressional tobacco control efforts, new entrants and innovative products entering the nicotine market, and public health distrust of the tobacco industry. Stefanie is a Managing Director at FiscalNote Markets where she also leads research in U.S. Politics and Elections, Trade Policy, and Cannabis. She appears frequently as a commentator on CNBC and Bloomberg TV, and is quoted frequently in financial press. Stefanie holds a Master of Business Administration from Georgetown University and a Bachelor Economics and Political Science from the University of Nebraska. JONATHAN M. SAMET,, a pulmonary physician and epidemiologist, is Dean of the Colorado School of Public Health. Previously, he was the Distinguished Professor and Flora L. Thornton Chair for the Department of Preventive Medicine at the Keck School of Medicine at the University of Southern California. His research has focused on the health risks of inhaled pollutants in outdoor air and also indoor pollutants including secondhand smoke and radon. He has also investigated the occurrence and causes of cancer and respiratory diseases, emphasizing the risks of active and passive smoking. He has served on and chaired numerous committees of the National Research Council and National Academy of Medicine, including chairing the Board on Environmental Studies and Toxicology. He serves on the Gulf Research Board. For several decades, he has been involved in global health, focusing on tobacco control, air pollution, and chronic disease prevention. He has been chair of the Clean Air Scientific Advisory Committee of the EPA and the FDA’s Tobacco Products Scientific Advisory Committee. Dr. Samet has served as Editor and Author for Reports of the Surgeon General on Smoking and Health since 1984, receiving the Surgeon General’s Medallion in 1990 and 2006 for these contributions. Dr. Samet received the 2004 Prince Mahidol Award for Global Health awarded by the King of Thailand, the Edward Livingston Trudeau Medal from the American Thoracic Society/American Lung Association, the Luther Terry Award for Distinguished Career from the American Cancer Society, and the Fries Prize for Health. He was elected to the National Academy of Medicine in 1997 and received the David Rall Medal in 2015.
JONATHAN M. SAMET,, a pulmonary physician and epidemiologist, is Dean of the Colorado School of Public Health. Previously, he was the Distinguished Professor and Flora L. Thornton Chair for the Department of Preventive Medicine at the Keck School of Medicine at the University of Southern California. His research has focused on the health risks of inhaled pollutants in outdoor air and also indoor pollutants including secondhand smoke and radon. He has also investigated the occurrence and causes of cancer and respiratory diseases, emphasizing the risks of active and passive smoking. He has served on and chaired numerous committees of the National Research Council and National Academy of Medicine, including chairing the Board on Environmental Studies and Toxicology. He serves on the Gulf Research Board. For several decades, he has been involved in global health, focusing on tobacco control, air pollution, and chronic disease prevention. He has been chair of the Clean Air Scientific Advisory Committee of the EPA and the FDA’s Tobacco Products Scientific Advisory Committee. Dr. Samet has served as Editor and Author for Reports of the Surgeon General on Smoking and Health since 1984, receiving the Surgeon General’s Medallion in 1990 and 2006 for these contributions. Dr. Samet received the 2004 Prince Mahidol Award for Global Health awarded by the King of Thailand, the Edward Livingston Trudeau Medal from the American Thoracic Society/American Lung Association, the Luther Terry Award for Distinguished Career from the American Cancer Society, and the Fries Prize for Health. He was elected to the National Academy of Medicine in 1997 and received the David Rall Medal in 2015. KENNETH MICHEAL CUMMINGS is a professor at the Medical University of South Carolina. He has a Master’s degree and PhD in Health Education and Health Behavior from the School of Public Health at the University of Michigan. He is currently a Professor in the Department of Psychiatry & Behavioral Sciences and member of the Hollings Cancer Center’s Cancer Prevention and Control Program where he co-leads the tobacco control research program. He joined the MUSC faculty in October 2011 and has been involved in establishing a tobacco dependence treatment service for patients seen in the University hospital and outpatient clinics. Before coming to MUSC, Dr. Cummings worked at the Roswell Park Cancer Institute (RPCI) in Buffalo, New York, where he was a senior research scientist and Chairman of the Department of Health Behavior.
KENNETH MICHEAL CUMMINGS is a professor at the Medical University of South Carolina. He has a Master’s degree and PhD in Health Education and Health Behavior from the School of Public Health at the University of Michigan. He is currently a Professor in the Department of Psychiatry & Behavioral Sciences and member of the Hollings Cancer Center’s Cancer Prevention and Control Program where he co-leads the tobacco control research program. He joined the MUSC faculty in October 2011 and has been involved in establishing a tobacco dependence treatment service for patients seen in the University hospital and outpatient clinics. Before coming to MUSC, Dr. Cummings worked at the Roswell Park Cancer Institute (RPCI) in Buffalo, New York, where he was a senior research scientist and Chairman of the Department of Health Behavior.















































